Nearly every clinician assesses urinary health from time to time; for example, ordering and interpreting a urine analysis and/or urine cul ture to detect a UTI. Clinicians providing care for women with lower urinary tract (LUT) disorders have also relied on these traditional urinary assessments in order to evaluate, diag nose, and treat affected patients. However, all of these assessments are based on the assump tion that the healthy female urinary bladder is sterile, an assumption that we now know to be incorrect. Since 2012, when microbes were detected in the female urinary bladder (the female urinary microbiota) 1 , additional and confirmatory evidence has clearly docu mented the presence of a living bacterial although these data were not statistically sig nificant (mean = 39 (P = 0.2)), group differ ences in OTU abundance (In UUI, nine more abundant and five less abundant, compared with controls), and significant individual variation in the number of bacterial families (range 2-49) detected per sample, as well as the diversity and richness of each sample. Overall, they concluded that increased symp tom distress and urgency incontinence epi sodes correlated with the characteristics of the urinary microbial community, which could be clinically important.
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The work of Karstens and colleagues 8 provides important and independent con firmation of work previously published by Pearce et al. 4 who first described differences in the urinary microbiota of women with UUI compared with those without such symptoms. Despite the small size of Karstens and colleagues' (REF. 8 ) cohorts, the findings are strengthened by the careful characteri zation and matching of the participants. In addition, the proportion of samples that were sequenced is high; this strength would have been further enhanced by the concomitant use of enhanced culturebased techniques 2, 3, 5 to confirm that the detected DNA arose from living microbes.
A complementary paper by ThomasWhite and coworkers 9 used preexisting samples collected in an NIH study designed to evaluate the treatment outcomes of well characterized women enrolled in a multi centre prospective randomized trial (the Value of Urodynamic Evaluation (ValUE) study) to assess the role of preoperative urodynamic testing before surgery for stress urinary incontinence (SUI). Women with concomitant UUI were included, as clinically appropriate. The study relied on samples (mostly obtained through voiding (n = 174), but some obtained through catheterization (n = 23)) obtained at baseline, before SUI treatment. Most (86%) community in the bladders of women with and without lower urinary symptoms [2] [3] [4] [5] [6] . This major paradigm shift raises many questions regarding the role of the female urinary micro biota in lower urinary tract health and disease.
Much more is known about the micro biota of other organs than that of the bladder. For example, the wellstudied gut microbiota are known to vary considerably based on diet ary intake and BMI. Studies that link the gut microbiota with CNS function highlight the biological importance of microbial niches throughout the human body. The urinary microbiota holds similar potential, especially given the wellknown connections between brain and bladder function 7 . Three papers published in 2016 have addressed several clinically relevant questions in the field. Karstens and coworkers 8 pro vided confirmatory evidence of the presence of bacterial communities in the bladders of women with and without lower urinary tract symptoms. In a carefully controlled study, these investigators collected catheterized urine samples from clinically well characterized women (mean age approximately 58 years) with urgency urinary incontinence (UUI, n = 10) and nine women without such symp toms. The investigators reported detection of relevant bacterial sequences in 95% of samples, and a median DNA content of 95 fg/mL with out group differences between women with and without symptoms. They also observed a higher number of operational taxonomic units (OTUs) in samples from women with UUI (mean = 49) compared with those without, Associating infection and incontinence with the female urinary microbiota
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The discovery and confirmation of the female urinary microbiota in 2012 provided opportunities to improve insight into lower urinary tract disorders in women, including UTI and urgency urinary incontinence. Now, research in 2016 has shown that expanded culture techniques enable improved uropathogen detection and confirm that bacteria detected by culture-independent methods are alive.
…enhanced urine culture techniques provide an opportunity to advance clinical care and refine best practices in antibiotic stewardship…
Key advances
• Most adult women have a detectable community of bacteria in their urine 1 • The characteristics of the female urinary microbiota relate to certain common lower urinary tract conditions, notably urgency urinary incontinence 8 • The standard urine culture is considerably limited in detection of organisms that make up the female urinary microbiota 5 • Enhanced quantitative urine culture techniques confirm that the DNA of the organisms detected by sequencing technology are living and cultivatable 5 • The female urinary microbiota seems to be associated with probability of successful treatment in certain women with urgency urinary incontinence of the 197 samples contained detectable levels of bacterial DNA. An important clini cal message was that no association with SUI symptoms was observed, in agreement with the fact that SUI and UUI have different aeti ologies. Similar to data from previous studies, the community characteristics -including diversity and organism predominance -of the urinary microbiota were associated with UUI symptoms. In addition, the large sample size meant that these investigators were also able to detect an association between hor monal status and BMI. Finally, they demon strated that increased diversity of the urinary microbial community was associated with a concomitant lower frequency of Lactobacillus in clinically postmenopausal women who are not taking exogenous oestrogen. A third paper by Price and coworkers 5 , addressed the clinical relevance of bacterial members of the urinary microbiota, focus ing on the ability of the standard urine cul ture protocol to detect microorganisms. The standard protocol has been refined to grow certain uropathogens, especially E. coli. However, standard urine culture conditions are not ideal for many other known human uropathogens. Hilt and coworkers 2 had pre viously described enhanced urine culture techniques that were established to grow organisms detected previously by sequencing. In 2016, Price et al. 5 extended this work to a clinically relevant population of women based on their selfreported UTI. A key message of this paper was the low rate of uropathogen detection using standard urine culture tech niques. Using baseline catheterized samples from 150 adults attending urogynaecology clinics, standard urine culture failed to detect 67% of uropathogens overall and 50% in participants with severe urinary symptoms. The investigators evaluated a variety of cul ture conditions to determine the optimal urine culture method that could be incor porated into any clinical laboratory for opti mizing the detection of uropathogens. They reported that 100 µL of urine plated onto Blood (BAP), Colistin Naladixic Acid (CNA), and MacConkey agars in 5% CO 2 for 48 h resulted in detection of 84% of all uro patho gens, versus just 33% with the commonly used standard urine protocol (FIG 1) .
Clinicians face a number of challenges when caring for women with lower urinary tract symptoms. The simple dichotomy of 'infection' or 'no infection' does not incorpo rate evidence documenting the existence of the female urinary microbiota. The spectrum of health, dysbiosis, and disease likely relates to the urinary microbial community, as it does to other human microbial niches. Reliance on standard urine culture alone might limit the information available to physicians; the addi tional information available from enhanced urine culture techniques helps inform clini cians of the status of the urinary microbiota, including the presence of uro pathogens that might be missed using standard urine culture protocols. The robust information generated by enhanced urine culture techniques provide an opportunity to advance clinical care and refine best practices in antibiotic stewardship and avoid use of interventions that wipe out bacterial communities that have a favourable biological function. 
